New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Rubicon Organics Inc.
ROMJF
Shape
US Flag

PNK

Unprofitable

Unprofitable

16M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

16M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

0.28USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-55%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

38%

Quote Panel

Shape
Updated October 21, 2024
1W -1.70 % 1M -15.50 % 3M -19.50 % 1Y -9.40 %

Key Metrics

Shape
  • Market Cap

    15.70M


  • Shares Outstanding

    56.27M


  • Share in Float

    31.60M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    0.279


  • Average Volume

    13268


  • Beta

    1.125


  • Range

    0.245-0.45


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.rubiconorganics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.53x

P/S Ratio

0.60x

P/B Ratio

0.3

Debt/Equity

-8.5%

Net Margin

$-0.1

EPS

How ROMJF compares to sector?

P/E Ratio

Relative Strength

Shape

ROMJF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$48M

Shape295%

2025-Revenue

$0.01

Shape-22%

2025-EPS

$23M

Shape-716%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-0.03
vs -0.06

Q2.22

arrow
arrow

N/A

-0.02
vs -0.09

Q3.22

arrow
arrow

+157%

0.04
vs -0.07

Q4.22

arrow
arrow

N/A

-0.04
vs -0.02

Q1.23

arrow
arrow

N/A

-0.01
vs -0.03

Q2.23

arrow
arrow

N/A

-0.00
vs -0.02

Q3.23

arrow
arrow

N/A

-0.02
vs 0.04

Q4.23

arrow
arrow

+115%

0.01
vs -0.04

Q1.24

arrow
arrow

N/A

-0.02
vs -0.01

Q2.24

arrow
arrow

N/A

-0.01
vs -0.00

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+49%

10.5M  vs 7.1M

Q4.22

arrow
arrow

+61%

11M  vs 6.8M

Q1.23

arrow
arrow

+71%

8.8M  vs 5.1M

Q2.23

arrow
arrow

+28%

11.3M  vs 8.8M

Q3.23

arrow
arrow

-5%

10M  vs 10.5M

Q4.23

arrow
arrow

-9%

10M  vs 11M

Q1.24

arrow
arrow

+1%

8.9M  vs 8.8M

Q2.24

arrow
arrow

+7%

12.1M  vs 11.3M

Q3.24

arrow
arrow

+23%

12.4M  vs 10M

Q4.24

arrow
arrow

+22%

12.2M  vs 10M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+5%

0.05
vs -0.03

Q4.22

arrow
arrow

-9%

-0.09
vs 0.05

Q1.23

arrow
arrow

-2%

-0.02
vs -0.09

Q2.23

arrow
arrow

0%

-0.00
vs -0.02

Q3.23

arrow
arrow

-4%

-0.04
vs -0.00

Q4.23

arrow
arrow

+1%

0.01
vs -0.04

Q1.24

arrow
arrow

-5%

-0.05
vs 0.01

Q2.24

arrow
arrow

-1%

-0.01
vs -0.05

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News

ROMJF

globenewswire.com

6 hours ago